Oberweis Asset Management Inc. grew its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 20.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 156,680 shares of the medical instruments supplier's stock after acquiring an additional 26,180 shares during the quarter. ICU Medical comprises 1.1% of Oberweis Asset Management Inc.'s investment portfolio, making the stock its 12th largest position. Oberweis Asset Management Inc. owned about 0.64% of ICU Medical worth $24,312,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of ICUI. Harvest Fund Management Co. Ltd bought a new stake in ICU Medical during the fourth quarter valued at approximately $33,000. Murphy & Mullick Capital Management Corp purchased a new stake in shares of ICU Medical during the 4th quarter valued at $52,000. Venturi Wealth Management LLC lifted its holdings in shares of ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock worth $82,000 after acquiring an additional 206 shares during the last quarter. Russell Investments Group Ltd. grew its position in ICU Medical by 88.8% in the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after acquiring an additional 300 shares in the last quarter. Finally, Sterling Capital Management LLC increased its stake in ICU Medical by 813.5% in the fourth quarter. Sterling Capital Management LLC now owns 676 shares of the medical instruments supplier's stock valued at $105,000 after acquiring an additional 602 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.
ICU Medical Trading Up 1.9 %
NASDAQ:ICUI traded up $2.57 during trading hours on Tuesday, hitting $138.47. The company had a trading volume of 53,437 shares, compared to its average volume of 273,235. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The stock has a 50-day moving average price of $143.25 and a 200 day moving average price of $157.64. The company has a market capitalization of $3.41 billion, a PE ratio of -30.26 and a beta of 0.86. ICU Medical, Inc. has a 52 week low of $95.44 and a 52 week high of $196.26.
Analyst Ratings Changes
ICUI has been the subject of a number of research reports. KeyCorp cut their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Raymond James set a $97.00 target price on ICU Medical in a research note on Wednesday, March 12th. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a research report on Tuesday, April 8th. Finally, StockNews.com lowered shares of ICU Medical from a "buy" rating to a "hold" rating in a report on Thursday, April 24th. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $162.67.
Read Our Latest Analysis on ICU Medical
ICU Medical Company Profile
(
Free Report)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.
See Also
Before you consider ICU Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ICU Medical wasn't on the list.
While ICU Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
